Biogen says potential MS drug outperforms placebo - BusinessWeek

[INCIID News Feed]

ThirdAge
<img alt="" height="1" width="1" />
Biogen says potential MS drug outperforms placebo
BusinessWeek
Biogen Idec Inc. said Friday that its potential treatment for a common form of multiple sclerosis did better than a placebo in reducing relapses in late-stage clinical testing. The Weston, Mass., company said the oral treatment reduced the portion of ...
Biogen MS trial data robust; shares jumpReuters
Biogen Idec, Abbott Say SELECT Phase 2B Trial For RRMS Compound Met Primary GoalRTT News
BG-12 Data Impress in Multiple SclerosisMedscape
Fox Business -Proactive Investors USA & Canada
all 74 news articles &raquo;


More...